Onset and Duration of Clinical Effect of IPX066 in Advanced Parkinson's Disease

被引：0
|
作者：
Ellenbogen, Aaron
Hauser, Robert A.
Modi, Nishit B.
Hsu, Ann
Khanna, Sarita
Gupta, Suneel
机构：
来源：
ANNALS OF NEUROLOGY | 2015年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S419
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] Onset and duration of clinical effect of IPX066, an extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease
    Ellenbogen, A.
    Hauser, R. A.
    Modi, N. B.
    Hsu, A.
    Khanna, S.
    Gupta, S.
    MOVEMENT DISORDERS, 2015, 30 : S80 - S80
  • [2] The Influence of Concomitant Medications on the Efficacy of IPX066 in Advanced Parkinson's Disease
    LeWitt, Peter A.
    Metman, Leo Verhagen
    Rubens, Robert
    Khanna, Sarita
    Kell, Sherron
    Gupta, Suneel
    ANNALS OF NEUROLOGY, 2015, 78 : S53 - S53
  • [3] COST-EFFECTIVENESS ANALYSIS OF IPX066 IN ADVANCED PARKINSON'S DISEASE
    Arnold, R. J.
    Frasco, M. A.
    Layton, A.
    Rustay, N. R.
    Chen, S.
    VALUE IN HEALTH, 2015, 18 (03) : S283 - S283
  • [4] Analysis of IPX066 Dosing Data in Advanced Parkinson's Disease (PD) Patients
    Hsu, Ann
    O'Connell, Martin
    Kell, Sherron
    Gupta, Suneel
    NEUROLOGY, 2013, 80
  • [5] Crossover Comparison of IPX066 and a Standard Levodopa Formulation in Advanced Parkinson's Disease
    Hauser, Robert A.
    Ellenbogen, Aaron L.
    Metman, Leo Verhagen
    Hsu, Ann
    O'Connell, Martin J.
    Modi, Nishit B.
    Yao, Hsuan-Ming
    Kell, Sherron H.
    Gupta, Suneel K.
    MOVEMENT DISORDERS, 2011, 26 (12) : 2246 - 2252
  • [6] Exploratory analysis of IPX066 on motor fluctuations in advanced Parkinson's disease (PD)
    Hsu, A.
    O'Connell, M.
    Khanna, S.
    Gupta, S.
    MOVEMENT DISORDERS, 2012, 27 : S122 - S122
  • [7] Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials
    Nausieda, Paul A.
    Hsu, Ann
    Elmer, Lawrence
    Gil, Ramon A.
    Spiegel, Joerg
    Singer, Carlos
    Khanna, Sarita
    Rubens, Robert
    Kell, Sherron
    Modi, Nishit B.
    Gupta, Suneel
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (04) : 837 - 845
  • [8] Dose conversion to IPX066 in advanced Parkinson's disease patients treated with carbidopa-levodopa-entacapone
    Hsu, A.
    Khanna, S.
    Kell, S.
    Espay, A.
    Gil, R.
    Singer, C.
    Gupta, S.
    MOVEMENT DISORDERS, 2013, 28 : S149 - S149
  • [9] Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
    Pahwa, Rajesh
    Lyons, Kelly E.
    Hauser, Robert A.
    Fahn, Stanley
    Jankovic, Joseph
    Pourcher, Emmanuelle
    Hsu, Ann
    O'Connell, Martin
    Kell, Sherron
    Gupta, Suneel
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (02) : 142 - 148
  • [10] Comparative efficacy and safety of a novel carbidopa-levodopa product (IPX066) and Sinemet in advanced Parkinson's disease
    Ellenbogen, A.
    Hauser, R.
    Omidvar, O.
    Hsu, A.
    O'Connell, M.
    Kell, S.
    Gupta, S.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S126 - S126
12345